Please enable / Bitte aktiviere JavaScript!
Veuillez activer / Por favor activa el Javascript!

“GSK cuts vaccine price for refugees, bowing to pressure” plus 8 more Reuters: Health News

loading...

“GSK cuts vaccine price for refugees, bowing to pressure” plus 8 more Reuters: Health News


GSK cuts vaccine price for refugees, bowing to pressure

Posted: 19 Sep 2016 04:42 AM PDT

LONDON (Reuters) - GlaxoSmithKline is cutting the price charged for its pneumococcal vaccine when given to refugees, following complaints about the product's "exorbitant" cost by medical charity Medecins Sans Frontieres.

Bayer raises sales targets for top-selling drugs after Monsanto deal

Posted: 20 Sep 2016 12:09 AM PDT

FRANKFURT (Reuters) - German drugmaker Bayer said its two best-selling drugs had a higher annual peak sales potential than previously targeted, after the agreed $66 billion takeover of Monsanto stirred criticism it might neglect its pharmaceuticals business.

Florida declares neighborhood Zika-free, but CDC remains cautious

Posted: 19 Sep 2016 12:46 PM PDT

(Reuters) - U.S. health officials on Monday urged pregnant women to consider putting off nonessential travel to Miami due to the Zika virus even as they lifted a travel warning for one neighborhood. Earlier in the day, Florida's governor declared the neighborhood of Wynwood Zika-free and invited visitors to return.

Wearable device helps reduce low blood sugar episodes

Posted: 19 Sep 2016 11:39 AM PDT

NEW YORK (Reuters Health) – - A new "flash" blood sugar monitoring system cuts down on episodes of low blood sugar in people with type 1 diabetes, researchers say.

Codeine not safe for kids, doctors warn

Posted: 19 Sep 2016 01:03 PM PDT

(Reuters Health) - Codeine isn't safe for children and shouldn't be used to ease pain or relieve coughs, a leading U.S. pediatricians group warns.

Bowing to pressure, FDA approves Sarepta's Duchenne drug

Posted: 19 Sep 2016 01:26 PM PDT

(Reuters) - Bowing to pressure from patient advocates, the U.S. Food and Drug Administration on Monday approved a treatment for Duchenne muscular dystrophy even though an outside panel of experts and the agency's own reviewers questioned the drug's efficacy.

Too little sleep, or too much, linked to risk of heart disease

Posted: 19 Sep 2016 03:30 PM PDT

(Reuters Health) - Sleep irregularities may be tied to a variety of health problems, such as diabetes and obesity, that can increase the risk of cardiovascular disease, a leading U.S. doctors group says.

In youngest suicide victims, ADD is more common than depression

Posted: 19 Sep 2016 03:22 PM PDT

(Reuters Health) - When children under 12 commit suicide, they are more likely to have a diagnosis of attention deficit disorder than depression, a U.S. study suggests.

Astellas, Vical herpes vaccine fails mid-stage study

Posted: 19 Sep 2016 04:53 AM PDT

(Reuters) - Japan's Astellas Pharma Inc and San Diego-based Vical Inc said their experimental herpes vaccine failed a mid-stage study involving certain kidney transplant patients.

Related Posts :